BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15530836)

  • 1. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
    Schultze JL; Grabbe S; von Bergwelt-Baildon MS
    Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dendritic cells: orchestration of the immune response].
    Martinon-Ego C; Berthier R
    Ann Biol Clin (Paris); 2000; 58(5):541-56. PubMed ID: 11022098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming anticancer active specific immunotherapy with dendritic cells.
    Mocellin S
    Curr Opin Investig Drugs; 2005 Jun; 6(6):576-81. PubMed ID: 15988908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of vaccines against self-antigens: the p53 paradigm.
    Chada S; Mhashilkar A; Roth JA; Gabrilovich D
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reengineering dendritic cell-based anti-cancer vaccines.
    Koski GK; Cohen PA; Roses RE; Xu S; Czerniecki BJ
    Immunol Rev; 2008 Apr; 222():256-76. PubMed ID: 18364007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in dendritic cell cancer immunotherapy.
    López JA; Hart DN
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dendrite cell-based cancer vaccines--clinical application].
    Svane IM; Berntsen A; Trepiakas R; Pedersen AE
    Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based cancer therapy.
    Conrad C; Nestle FO
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of dendritic cells in cancer immunotherapy.
    Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell immunotherapy: mapping the way.
    Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
    Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.